WESLEY JOHNSON - 11 Apr 2022 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role: Director
Signature: /s/ Richard C. Rosenzweig, Attorney in Fact
Issuer symbol: ANGO
Transactions as of: 11 Apr 2022
Transactions value $: -$172,838
Form type: 4
Filing time: 13 Apr 2022, 16:07:18 UTC
Previous filing: 30 Jul 2021
Next filing: 18 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANGO	Common Stock	Sale	-$142,623	-6,201	-7.2%	$23	80,003	11 Apr 2022	Direct	F1
transaction	ANGO	Common Stock	Sale	-$30,214	-1,299	-1.6%	$23.26	79,704	12 Apr 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.01, inclusive. The reporting person has provided to AngioDynamics, Inc. (the "Company"), and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.20 to $23.36, inclusive. The reporting person has provided to the Company, and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.01, inclusive. The reporting person has provided to AngioDynamics, Inc. (the "Company"), and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.20 to $23.36, inclusive. The reporting person has provided to the Company, and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.